Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Anaplastic Thyroid Cancer Drugs Market: By Product: Chemotherapy, Novel Therapy; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Anaplastic Thyroid Cancer Drugs Market Outlook

The global anaplastic thyroid cancer drugs market size will grow at a CAGR of 5% during the forecast period of 2021-2026. The introduction of targeted therapies is one of the main growth drivers of the global market for anaplastic thyroid cancer drugs.

 

Anaplastic Thyroid Cancer Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Anaplastic thyroid cancer is a type of thyroid cancer that, due to its aggressive actions and cancer treatment resistance, has a very poor prognosis. It has a low differentiation of its anaplastic cells, including dedifferentiation. The anaplastic thyroid cancer drugs industry can be divided on the basis of segments like product types. The industry can be broadly categorised on the basis of product into:

 

Anaplastic Thyroid Cancer Drugs Market by Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Chemotherapy
  • Novel Therapy

The EMR report looks into the global anaplastic thyroid cancer drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Anaplastic Thyroid Cancer Drugs Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Potential treatments may benefit from increasing research and development and successful clinical trials involving specific protein targets. These target treatments have been shown to be more effective than off-level therapies, such as chemotherapy used in anaplastic thyroid carcinoma treatment. Through the accessibility of chemotherapy reimbursement programs would enable more patients with anaplastic thyroid cancer to use off-label therapy to treat anaplastic thyroid cancer, leading to an increase in the patient base, thus, aiding the global anaplastic thyroid cancer drugs industry. For patients and health care facilities, the high cost of chemotherapeutics has been a major challenge. Governments and organisations are, therefore, focusing on providing financial and medical resources to combat different types of cancer. These reimbursement programs contribute to a broader base of clients and help them stick to therapy for a longer-term, which is boosting the growth of the global anaplastic thyroid cancer drugs industry.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global anaplastic thyroid cancer drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Bristol-Myers Squibb Co. (NYSE: BMY)
  • Celgene Corp. 
  • Eisai Co., Ltd
  • Johnson & Johnson Services, Inc. 
  • Novartis AG  
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Anaplastic Thyroid Cancer Drugs Market Analysis
    6.1    Global Anaplastic Thyroid Cancer Drugs Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Anaplastic Thyroid Cancer Drugs Market Breakup by Product
        6.2.1    Chemotherapy
        6.2.2    Novel Therapy
    6.3    Global Anaplastic Thyroid Cancer Drugs Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Chemotherapy
        6.3.2    Novel Therapy
    6.4    Global Anaplastic Thyroid Cancer Drugs Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Argentina
            6.4.4.3    Mexico
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5     Global Anaplastic Thyroid Cancer Drugs Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Argentina
            6.5.4.3    Mexico
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Key Players & Company Profiles
    9.1    Bristol-Myers Squibb Co.  (NYSE: BMY)
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Celgene Corp.  (NASDAQ: CELG)
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Eisai Co., Ltd 
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Johnson & Johnson Services, Inc. (JNJ (NYSE))
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Novartis AG (SWX: NOVN)
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Others
10    Industry Events and Developments

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 5% between 2021 and 2026.

The major drivers of the market include the introduction of targeted therapies and reimbursement programs driven by governments and organizations.

Accessibility of chemotherapy reimbursement programs would enable more patients with anaplastic thyroid cancer to use off-label therapy to treat anaplastic thyroid cancer, thus aiding the global anaplastic thyroid cancer drugs industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Chemotherapy and novel therapy are the two main products of anaplastic thyroid cancer drugs market.

The major players in the industry are Bristol-Myers Squibb Co., Celgene Corp., Eisai Co., Ltd, Johnson & Johnson Services, Inc., and Novartis AG, among others.

Analyst Review

The global anaplastic thyroid cancer drugs market is driven by the introduction of targeted therapies and increasing research and development and successful clinical trials involving specific protein targets. Aided by various patient reimbursement programs by the government and organizations. the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 5%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product, the anaplastic thyroid cancer drugs industry can be segmented into chemotherapy and novel therapy, with chemotherapy accounting for the largest market share. The major regional markets for anaplastic thyroid cancer drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bristol-Myers Squibb Co., Celgene Corp., Eisai Co., Ltd, Johnson & Johnson Services, Inc. and Novartis AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

United States Compounding Pharmacies Market Report and Forecast 2021-2026


Global Anaesthesia Drugs Market Report and Forecast 2021-2026


United States HIV Drugs Market Report and Forecast 2021-2026


Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026


Global Nootropics Market Report and Forecast 2021-2026


NEWSLETTER